LYKALABS.NS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: March 16, 2026
Report Source: 2026 3rd Quarter Report
Lyka Labs Ltd. Stock Analysis LYKALABS.NS
Lyka Labs Ltd. is a holding company, which engages in the manufacture of pharmaceutical formulations and active pharmaceutical ingredients. The company employs 499 full-time employees The firm manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. The company offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The firm's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.
Read More Lyka Labs Ltd (LYKALABS.NS) Chart
Key Statistics of Lyka Labs Ltd (LYKALABS.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹62.37Volume
5438.00P/E Ratio (TTM)
27.7952 Week Range
Market Cap
2.20BAvg. Volume
24.83KDividend Yield
-Financial Metrics & Statements of Lyka Labs Ltd (LYKALABS.NS)
FAQ's for Lyka Labs Ltd (LYKALABS.NS)
- According to Musaffa’s Shariah screening methodology, Lyka Labs Ltd (LYKALABS.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.